Clinical Trial Update: Rivaroxaban vs Warfarin in Patients With Mechanical Heart Valves [Phase 3]

View source ↗

Summary

Phase 3 clinical trial comparing rivaroxaban to warfarin in patients with mechanical heart valves is currently enrolling by invitation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Valvular Heart Disease

Drugs mentioned

• Coumadin (warfarin)
• Xarelto (rivaroxaban)

Snippet

Sponsor: Rawalpindi Institute of Cardiology | Conditions: Valvular Heart Disease Patients | Phase 3 | Status: ENROLLING_BY_INVITATION